François-Emery Cotté

9PUBLICATIONS
42CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Nanotoxicology, health and safetyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Use of Disopyramide in Obstructive Hypertrophic Cardiomyopathy: A European Insight.

|Jun 06, 2025
Nationwide extrapolation of economic benefit of therapeutic innovation: a 10-year retrospective budget impact of direct oral anticoagulants introduction in France.

C Guilmet, H Lesage, F E Cotté

|May 13, 2025
Immunosuppressive treatment patterns in kidney transplant recipients in France: an insurance claims database study (OISTER) over a 12 year period.

Dany Anglicheau, Antoine Durrbach, Isabelle Bardoulat

|Jan 27, 2023
Cost-effectiveness of idecabtagene vicleucel compared with conventional care in triple-class exposed relapsed/refractory multiple myeloma patients in Canada and France.

Korinna Karampampa, Wenjie Zhang, Meena Venkatachalam

|May 19, 2022
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France.

Valentine Grumberg, Christos Chouaïd, François-Emery Cotté

|Feb 03, 2022
Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.

Christos Chouaïd, Valentine Grumberg, Alexandre Batisse

Pageof 2

Frequent Collaborators

4 joint publications

Anne-Françoise Gaudin

3 joint publications

Valentine Grumberg

2 joint publications

Jean-Baptiste Assié

2 joint publications

Christos Chouaïd